… The nanoparticles were prepared by the slightly modified nano-… that prepared RIV-loaded
PLGA NPs (F1) was optimized … SEM study confirms the prepared nanoparticles depicted non-…

… Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization,
in … Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using …

… disease clinically characterized by progressive loss of memory… in order to optimize preparation
process and encapsulate the … was faster in PBCA NP and slower in PLGA NP and showed …

… They can be designed and modified with different surface characteristics to optimize their …
ity by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles…

… Wistar rats after intravenous injection of rivastigmine-loaded NPs was also evaluated and
compared … In a subsequent investigation, rivastigmine was loaded on either PLGA or PBCA as …

… to its rapid biodegradation characteristics and its low solubility in … of rivastigmine-loaded
PLGA nanoparticles administered … successfully optimized to achieve high drug loading and EE. …

… Also, for the treatment of AD, rivastigmine-loaded PBCA NPs have been optimized. The …
the NPs replaced PBCA by to PLGA, generally presenting similar characteristics. According to …

… of factorial, characterized to utilizing the polymers of biodegradable, PBCA, and PLGA of …
applied on the development and optimization of solid lipid nanoparticle (SLN) formulation of …

… .; Pal, D.; Mitra, AK Preparation and characterization of folate conjugated … Rivastigmine-loaded
L-lactide-depsipeptide polymeric nanoparticles: Decisive formulation variable optimization…

… Rivastigmine-loaded in situ gelling NLCs produced by ethanol … liposomes for brain
targeting: Preparation, characterization, ex … Preparation and optimization of rivastigmine-loaded …